Dec 07,2016

BioTelemetry buys TelCare for $7M to branch out into diabetes

BioTelemetry, formerly known as CardioNet, has acquired TelCare, a diabetes management technology company with the distinction of having had the first FDA-cleared, cellular-connected glucometer. BioTelemetry paid $7 million in cash with the potential for additional performance-based earn-outs of up to $5 million, also in cash. Both BioTelemetry and TelCare are veterans of the early days of the mobile health space.

COLLABORATION MERGERS & ACQUISITION
View Analyst & Ambassador Comments
Go to original news
Dec 07,2016

Medtronic, Fitbit partner to integrate data from CGM device, activity tracker into one app

Medical device maker Medtronic has teamed up with Fitbit to integrate physical activity data with blood glucose levels into one streamlined application. People living with type 2 diabetes who use Medtronic's iPro2 continuous glucose monitoring system and its companion app, iPro2 myLog, will now be able to have their Fitbit data automatically synced to the app, enabling them to easily see the connection between their exercise and glucose levels.

COLLABORATION PARTNERSHIP

#connected device

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 12,2016

Noom adopts outcomes-based pricing for wellness, prevention programs

While the path to value-based care is necessarily a slow one for hospitals and health systems, prevention programs – focused on a single outcome measure for a single condition – are in a position to lead the way in charging for outcomes. Omada Health, the first digital diabetes prevention program, has been charging only for successful outcomes for a while. Noom announced yesterday that it will do the same, not only for diabetes but also for obesity, prediabetes, and hypertension.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Dec 20,2016

FDA approves Dexcom G5 for use without a fingerstick glucometer

The FDA has officially cleared the Dexcom G5 continuous glucose monitor to inform treatment decisions -- without the use of a fingerstick glucometer, other than for calibration. The G5 has been cleared for a while to complement a traditional glucometer, but this non-adjunctive clearance is the first of its kind according to Dexcom and the FDA, which both released statements.

REGULATORY FDA

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 01,2016

Pen needle design influences ease of insertion, pain, and skin trauma in subjects with type 2 diabetes

Pen needles used for subcutaneous injections have gradually become shorter, thinner and more thin walled, and thereby less robust to patient reuse. Thus, different needle sizes, alternative tip designs and needles resembling reuse were tested to explore how needle design influences ease of insertion, pain and skin trauma.

CLINICAL STUDY

#insulin pen

View Analyst & Ambassador Comments
Go to original news
Dec 02,2016

Senseonics Expands Distribution Agreement with Roche

Senseonics Holdings, Inc. (NYSE-MKT:SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced it has expanded its exclusive distribution agreement with Roche to include all of Europe, the Middle East and Africa (EMEA), excluding Scandinavia, Finland and Israel. In May of this year, Senseonics signed an exclusive distribution with Roche for the commercialization of Senseonics’ Eversense® Continuous Glucose Monitoring System in Germany, Italy and the Netherlands.

COLLABORATION PARTNERSHIP

#product & service

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 05,2016

DarioHealth Ends a Successful Diabetes Awareness Month

DarioHealth Corp. (NASDAQ: DRIO), a leader in digital health and mobile health solutions, announced today that user-engagement metrics were higher during November 2016 when compared to the month of October 2016 due in part to Diabetes Awareness Month and new user-engagement strategies that were implemented. "During Diabetes Awareness Month, we welcomed thousands of new registrants. In the U.S. alone, we had over 4,000 new sign-ups," explained Erez Raphael, DarioHealth's Chief Executive Officer.

View Analyst & Ambassador Comments
Go to original news
Dec 06,2016

One Drop Announces FDA Clearance and One Drop | Premium Launch in US, UK, and EU

One Drop today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité Européene (CE) mark approval for One Drop | Chrome, a beautiful blood glucose monitoring system that marries modern design with advanced medical and mobile technology.

REGULATORY FDA

#bgm

View Analyst & Ambassador Comments
Go to original news
Dec 08,2016

Vida Health, the app that pairs patients with health coaches, nabs $18 million more from investors

Vida Health, a two-year-old, Palo Alto, Ca.-based subscription-based app that pairs patients with health coaches, has raised $18 million in Series B funding led by Canvas Ventures, with participation from Nokia Growth and earlier backers Aspect Ventures and Khosla Ventures.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 14,2016

One Drop Announces Inaugural Members of the One Drop | Experts Advisory Board

One Drop today announced the One Drop | Experts Advisory Board and its six inaugural members, including healthcare professionals and clinical researchers, as well as people living with diabetes.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES